| Proteogenomic characterization of endometrial carcinoma Y Dou, EA Kawaler, DC Zhou, MA Gritsenko, C Huang, L Blumenberg, ... Cell 180 (4), 729-748. e26, 2020 | 325 | 2020 |
| Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural Variations EL Hoskins, E Samorodnitsky, MR Wing, JW Reeser, JF Hopkins, ... JCO precision oncology 7, e2200300, 2023 | 3 | 2023 |
| A systematic approach for detection of tumor genomic alterations which alter the immune microenvironment R Vella, EL Hoskins, JW Reeser, MR Wing, E Samorodnitsky, A Paruchuri, ... Cancer Research 83 (7_Supplement), 6645-6645, 2023 | | 2023 |
| Clinical impact of FGFR inhibitors on FGFR2 positive pancreatic cancer L Stein, JW Reeser, MR Wing, K Murugesan, A Paruchuri, Z Risch, ... Cancer Research 83 (7_Supplement), 3395-3395, 2023 | | 2023 |
| Pan-cancer landscape and impact of PD-L1 and PD-L2 structural variation EL Hoskins, E Samorodnitsky, MR Wing, JW Reeser, J Hopkins, ... Cancer Research 82 (12_Supplement), 761-761, 2022 | | 2022 |
| Pan-cancer landscape of CD274 (PD-L1) and PDCD1LG2 (PD-L2) structural variations. EL Hoskins, E Samarodnitsky, M Wing, J Reeser, J Hopkins, ... Journal of Clinical Oncology 40 (16_suppl), 3133-3133, 2022 | | 2022 |
